Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer. Umeh-Garcia M, O'Geen H, Simion C, Gephart MH, et al. Br J Cancer 2022 Apr 19. pii: 10.1038/s41416-022-01812.

Read + Share

Amedeo Smart

Independent Medical Education

Umeh-Garcia M, O'Geen H, Simion C, Gephart MH, et al. Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer. Br J Cancer 2022 Apr 19. pii: 10.1038/s41416-022-01812.
PMID: 35440669